ATC-Gruppen
- L04AA49 Peficitinib
- L04AA50 Ponesimod
- L04AA51 Anifrolumab
- L04AA52 Ofatumumab
- L04AA53 Teprotumumab
- L04AB Tumornekrosefaktor alpha (TNF-alpha)-Inhibitoren
- L04AB01 Etanercept
- L04AB02 Infliximab
- L04AB03 Afelimomab
- L04AB04 Adalimumab
- L04AB05 Certolizumab pegol
- L04AB06 Golimumab
- L04AB07 Opinercept
- L04AC Interleukin-Inhibitoren
- L04AC01 Daclizumab
- L04AC02 Basiliximab
- L04AC03 Anakinra
- L04AC04 Rilonacept
- L04AC05 Ustekinumab
- L04AC07 Tocilizumab